Home Newsfeeds SVB Leerink Maintains Outperform on Bio-Techne, Lowers Price Target to $110

SVB Leerink Maintains Outperform on Bio-Techne, Lowers Price Target to $110

SVB Leerink analyst Puneet Souda maintains Bio-Techne (NASDAQ:TECH) with a Outperform and lowers the price target from $125 to $110.

byBenzinga Newsdesk

February 3, 2023

1 minute read

SVB Leerink analyst Puneet Souda maintains Bio-Techne (NASDAQ:TECH) with a Outperform and lowers the price target from $125 to $110.

Block Eyes Strong Growth, Anticipates Q1 Wins and Expands Ambitions for 2024: BofA Analyst

By Anusuya Lahiri

April 22, 2:24 PM

Analyst reiterates Buy rating on SQ with $93 price target due to potential for strong Q1 results and ambitious long-term goals. SQ up 0.70%.

Manhattan Associates Q2 EPS $0.69 Beats $0.53 Estimate, Sales $191.90M Beat $180.19M Estimate

By Benzinga Newsdesk

July 26, 4:10 PM

Manhattan Associates (NASDAQ:MANH) reported quarterly earnings of $0.69 per share which beat the analyst consensus estimate of $0.53 by 30.19 percent. This is a 13.11 percent increase over earnings of $0.61 per share

MANH

AgEagle Aerial Systems Appoints William Irby As President, Effective February 12, 2024

By Benzinga Newsdesk

February 15, 9:07 AM

Established leader in the Unmanned Aerial System (UAS) sector to focus on driving sustainable growthWICHITA, Kan., Feb. 15, 2024 (GLOBE NEWSWIRE) -- AgEagle Aerial Systems Inc. (NYSE:UAVS) a leading provider of

UAVS

EXCLUSIVE: Diagnostics Provider Avalon GloboCare’s Subsidiary Launches New Laboratory Test For Tuberculosis

By Vandana Singh

August 30, 8:45 AM

Avalon GloboCare Corp (NASDAQ: ALBT) announced that Laboratory Services MSO (LSM) is now offering an in-house laboratory-developed test to detect tuberculosis using a patient’s sputum sample. Avalon owns a 40% interest in Laboratory Services (LSM).

ALBT

SVB Leerink Maintains Outperform on Bio-Techne, Lowers Price Target to $110

Related Posts

Block Eyes Strong Growth, Anticipates Q1 Wins and Expands Ambitions for 2024: BofA Analyst

Manhattan Associates Q2 EPS $0.69 Beats $0.53 Estimate, Sales $191.90M Beat $180.19M Estimate

AgEagle Aerial Systems Appoints William Irby As President, Effective February 12, 2024

EXCLUSIVE: Diagnostics Provider Avalon GloboCare’s Subsidiary Launches New Laboratory Test For Tuberculosis